Counterfeit Medicines Are a Problem in the European Union—A Problem that is Continuing to Grow

According to a report from Europol’s Intellectual Property Crime Threat Assessment 2019, “Counterfeit pharmaceuticals pose a growing threat to the EU, affecting a large number of Member States. A wide and increasingly diverse range of medicines is targeted by counterfeiters.”
The Europol ICP Threat Assessment reports that there has been an increase in seizures of counterfeit drugs used in the treatment of serious illnesses, as well as a growing number of counterfeit drug incidents affecting the legal drug supply chain. 


German Pharmacy Board: Country’s Drug Supply Chain is Safe

Germany’s pharmacy association recently affirmed its belief in the security of the country’s pharmaceutical supply chain. The ABDA said that Germans should be confident when taking their medication despite some reports of counterfeit drugs in the country, according to “The safest way to get drugs in Germany is any one of the 21,500 community…


Heparin Havoc Continues

Bryan A. Liang, MD, PhD, JD

It looks as though the problems from China-sourced heparin are far from over.  An unknown substance, similar in chemical makeup to heparin, has been found in batches of the blood thinner produced by U.S.-based Baxter International and Germany-based Rotexmedica.